OMS Trace Analytics

Deliver personalized patient care with the only histologically validated, objective, and quantitative CTA-based arterial analysis software. Utilize ground-truth histology to visualize the source of myocardial ischemia and inform heart attack and stroke risk. Heart attack and stroke are primarily caused by non-obstructive, but unstable plaque in the arteries that goes undiagnosed and untreated. Current non-invasive testing cannot visualize the biology deep inside artery walls where heart disease develops. Elucid is harnessing scientific imaging and artificial intelligence to enable quick, accurate, noninvasive diagnoses and precise treatment of cardiovascular disease to enable better patient outcomes. Assess plaque composition with histology-validated software. Quantify heart attack and stroke risk with greater accuracy. Visualize a comprehensive and objective view of arterial disease to enable personalized treatment plans before a patient ever enters the hospital.

Artrya partners with clinics receiving chest pain patients to deliver new models of cardiovascular care based on AI. Easily integrate plaque features of high prognostic value into the evaluation of coronary artery disease. Rapid assessment of chest pain patients in emergency and primary care settings. We see a world where communities do not have to be plagued by a high rate of a heart attack. AI-driven insights into the type and volume of arterial plaque detected through coronary computed tomography angiography (CCTA) facilitate the accurate stratification of chest pain patients within minutes. Quickly determine patients with minimal to zero coronary artery disease with the confidence there are no underlying plaque features that could cause future major adverse cardiac events. Catch the early warning signs of a potential heart attack. Effectively rule in at-risk patients with acute or atypical chest pain who warrant further investigation and therapy.